Phase 1 Clinical Trial of the Novel Structure Proteasome Inhibitor NPI-0052

被引：0

作者：

Spencer, Andrew ^{[1
]}

Millward, Michael ^{[2
,3
]}

Mainwaring, Paul ^{[4
]}

Harrison, Simon ^{[5
]}

Catley, Laurence ^{[6
]}

Townsend, Amanda ^{[7
]}

Sukumaran, Shawgi ^{[7
]}

Longenecker, Angie M. ^{[8
]}

Palladino, Michael A. ^{[8
]}

Lloyd, G. Kenneth ^{[8
]}

Neuteboom, Saskia ^{[8
]}

Padrik, Peeter ^{[9
]}

Spear, Matthew A. ^{[8
]}

Price, Timothy ^{[7
]}

机构：

[1] Alfred Hosp, Melbourne, Vic, Australia

[2] Sir Charles Gairdner Hosp, Perth, WA 6000, Australia

[3] Univ Western Australia, Perth, WA 6009, Australia

[4] Mater Hosp, Brisbane, Qld, Australia

[5] Peter MacCallum Canc Inst, Dept Hematol, Melbourne, Vic 3000, Australia

[6] Mater Adult Hosp, Canc Serv, Brisbane, Qld, Australia

[7] Queen Elizabeth Hosp, Adelaide, SA, Australia

[8] Nereus Pharmaceut Inc, San Diego, CA USA

[9] Tartu Univ Hosp, Tartu, Estonia

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1053 / 1054

页数：2

共 50 条

[41] Clinical trial of NPI-0052 in advanced malignancies including lymphoma and leukemia (advanced malignancies arm)
Townsend, A. R.
Millward, M.
Price, T.
Mainwaring, P.
Spencer, A.
Longenecker, A.
Palladino, M. A.
Lloyd, G. K.
Spear, M. A.
Padrik, P.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[42] Analysis of reactive oxygen species (ROS) generation and caspase-8 activation by analogues of proteasome inhibitor NPI-0052
Hale, Randal
Miller, Claudia
Manam, Rama
Macherla, Venkat
Palladino, Michael
Potts, Barbara
Chandra, Joya
CANCER RESEARCH, 2009, 69
[43] The novel proteasome inhibitor NPI-0052 plus TRAIL (TNF related apoptosis inducing ligand) activates the extrinsic apoptotic pathway in pancreatic cancer
Sundi, D.
Fournier, K.
Wray, C.
McConkey, D.
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 70 - 71
[44] Induction of Raf-1 kinase inhibitory protein (RKIP) by the proteasome inhibitor NPI-0052 and reversal of B-NHL resistance to apoptosis
Baritaki, Stavroula
Yeung, Kam
Chatterjee, Pevasis
Palladino, Michel
Bonavida, Benjamin
BLOOD, 2007, 110 (11) : 248A - 248A
[45] The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia
Ruiz, Stacey
Krupnik, Yelena
Keating, Michael
Chandra, Joya
Palladino, Michael
McConkey, David
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (07) : 1836 - 1843
[46] Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma
Chauhan, Dharminder
Singh, Ajita
Brahmandam, Mohan
Podar, Klaus
Hideshirna, Teru
Richardson, Paul
Munshi, Nikhil
Palladino, Michael A.
Anderson, Kenneth C.
BLOOD, 2008, 111 (03) : 1654 - 1664
[47] Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction
Baritaki, S.
Chapman, A.
Yeung, K.
Spandidos, D. A.
Palladino, M.
Bonavida, B.
ONCOGENE, 2009, 28 (40) : 3573 - 3585
[48] Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction
S Baritaki
A Chapman
K Yeung
D A Spandidos
M Palladino
B Bonavida
Oncogene, 2009, 28 : 3573 - 3585
[49] NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
Miller, Claudia P.
Ban, Kechen
Dujka, Melanie E.
McConkey, David J.
Munsell, Mark
Palladino, Michael
Chandra, Joya
BLOOD, 2007, 110 (01) : 267 - 277
[50] Requirement of caspase-8 versus caspase-9 during apoptosis in multiple myeloma cells induced by Bortezomib -: Or a novel proteasome inhibitor NPI-0052
Chauhan, D
Catley, L
Velankar, M
Letai, A
Hideshima, T
Podar, K
Yasui, H
Mitsiades, N
Mitsiades, C
Tai, YT
Raje, N
Munshi, N
Palladino, MA
Anderson, KC
BLOOD, 2005, 106 (11) : 944A - 944A

← 1 2 3 4 5 →